🍽🦠 PubMed Studies Citing Bacteria Shifts for Pediococcus pentosaceus {P. pentosaceus} - Bifidobacterium saguini

Citations are updated once a week. Recently added citations may not appear.

3 Citations Found, Full List Requires Login Summary Publisher Link Html Article Download Article Why do I only have some/no links buttons showing?
πŸ““ - Direct Citation   |   πŸ‘ͺ - Infer Parent  |   πŸ‘Ά - Infer Child |   βš—οΈ - Inferred from bacteria association
For Samples: 😁 - Shifts in right direction   |   😒 - Shifts in wrong direction
Context Citation
Pediococcus pentosaceus {P. pentosaceus} - Bifidobacterium saguini    👶 Potential Health Benefits of Yeast-Leavened Bread Containing LAB Pediococcus pentosaceus Fermented Pitaya (Hylocereus undatus): Both In Vitro and In Vivo Aspects.
Foods (Basel, Switzerland) (Foods ) Vol: 11 Issue 21 Pages:
Pub: 2022 Oct 28 Epub: 2022 Oct 28 Authors Omedi JO , Li N , Chen C , Cheng X , Huang J , Zhang B , Gao T , Liang L , Zhou Z , Huang W ,
Html Article Publication
Pediococcus pentosaceus {P. pentosaceus} - Bifidobacterium saguini    👶 Pediococcus pentosaceus CECT 8330 protects DSS-induced colitis and regulates the intestinal microbiota and immune responses in mice.
Journal of translational medicine (J Transl Med ) Vol: 20 Issue 1 Pages: 33
Pub: 2022 Jan 15 Epub: 2022 Jan 15 Authors Dong F , Xiao F , Li X , Li Y , Wang X , Yu G , Zhang T , Wang Y ,
Html Article Publication
Pediococcus pentosaceus {P. pentosaceus} - Bifidobacterium saguini    👶 Modulation of Intestinal Barrier, Inflammatory Response, and Gut Microbiota by Pediococcus pentosaceus zy-B Alleviates Vibrio parahaemolyticus Infection in C57BL/6J Mice.
Journal of agricultural and food chemistry (J Agric Food Chem ) Vol: 70 Issue 6 Pages: 1865-1877
Pub: 2022 Feb 16 Epub: 2022 Feb 2 Authors Wang R , Deng Y , Zhang Y , Li X , Sun L , Deng Q , Liu Y , Gooneratne R , Li J ,
Publication

BOOM

All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.

Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.


The awesome web hosting site that we use. Try it if you need to host (or unhappy with current provider)